Humacyte (HUMA) Interest & Investment Income (2020 - 2026)
Humacyte (HUMA) reported Interest & Investment Income of $330000.0 for Q1 2026, down 50.15% year-over-year from $662000.0 in Q1 2025, and down 34.39% quarter-over-quarter from $503000.0 in Q4 2025.
Humacyte (HUMA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Interest & Investment Income data on file, last reported at $330000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $330000.0, down 50.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 39.63% YoY), and the FY2025 annual result was $2.6 million, down 36.96% from the prior year.
- Interest & Investment Income eased to $330000.0 in Q1 2026 per HUMA's latest filing, from $503000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.5 million in Q2 2023 and troughed at $31000.0 in Q1 2022.
- A 5-year average of $889235.3 and a median of $883000.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income surged 29333.33% in 2022, then slumped 50.15% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $1.4 million in 2022, then decreased by 19.09% to $1.1 million in 2023, then retreated by 25.52% to $852000.0 in 2024, then slumped by 40.96% to $503000.0 in 2025, then tumbled by 34.39% to $330000.0 in 2026.
- Business Quant data shows HUMA's Interest & Investment Income at $330000.0 in Q1 2026, $503000.0 in Q4 2025, and $590000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 503,000.00 |
| Sep 30, 2025 | 590,000.00 |
| Jun 30, 2025 | 832,000.00 |
| Mar 31, 2025 | 662,000.00 |
| Dec 31, 2024 | 852,000.00 |
| Sep 30, 2024 | 911,000.00 |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 883,000.00 |
| Jun 30, 2022 | 301,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 2,000.00 |